Analog Devices and LifeQ collaborate on non-invasive body monitoring
May 3, 2016
Semiconductor company Analog Devices is collaborating with LifeQ to develop technology that will make it possible for non-invasive body monitoring devices to provide highly accurate physiological data that currently is only available through the use of expensive, invasive and hard-to-access equipment.
By combining the engineering and innovation of Massachusetts-based Analog Devices with the bio-mathematical capabilities of Georgia, USA, company LifeQ, the two firms plan to design sensors that enable personalised, continuous and accurate tracking of physiological parameters such as heart rate, sleep phases, sleep quality, blood lactate, 24-hour calorie intake as well as stress markers such as salivary cortisol.
Monitoring this type of data can increase early detection of emergency conditions and diseases in at-risk patients.
“The development of smart wearable sensors is essential to supercharge the next generation of non-invasive body monitoring,” said James Doscher, general manager, of Analog Devices’ industrial and business healthcare group. “ADI offers the semiconductor expertise and LifeQ provides the bio-mathematical understanding needed to develop sensors that can make body monitoring devices even more effective in preventing, predicting and managing diseases. This, in turn, will impact how doctors and patients share information, interact, and make decisions about patient care. Patients can have greater access to vital data about their own bodies and be more involved in their overall health and wellness.”
ADI’s portfolio of linear, mixed-signal, microelectromechanical systems and digital processing technologies are used in healthcare diagnostics, clinical monitoring equipment, life science and medical instrumentation, and health and wellness device designs.
With its computational systems biology expertise, LifeQ deals with the construction and acquisition of information from bio-sensors. Combined with the patented LifeQ bio-mathematical engine, a range of physiological measures that are currently inaccessible, costly and invasive are now available both through wearable devices and via LifeQ's API.
"LifeQ’s collaboration with ADI will enable sensor solutions that meet a higher and wider standard, including new industry benchmarks such as the latest Android Wear requirements,” said Riaan Conradie, co-founder and chief operating officer of LifeQ. “Our goal is to deliver high-value physiological data to ecosystem partners who are serving consumer lifestyle, corporate wellness and health insurance markets."